HLA-C and COVID-19: In comparison with controls, a non-significant difference in HLA-C*04:01 allele frequency was observed for the COVID-19 patients with mild/moderate (P=0.93) and severe (P=0.15) symptoms composing the group of hospitalized inpatients (Figure S3A).